Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tarrytown, NY
SEC filing record 1 source field available
Fiscal year end
31 December
REGENERON PHARMACEUTICALS, INC. has filed 2,471 SEC EDGAR filings since 26 Jul 1995

SEC filing history

Showing 76-100 of 206 matching filings.

Per page
25
Current page
4
8-K File 000-19034

8-K

Filing date
07 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
17 Dec 2018
Reporting date
14 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

FORM 8-K

Filing date
06 Nov 2018
Reporting date
06 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
12 Oct 2018
Reporting date
10 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

FORM 8-K

Filing date
02 Aug 2018
Reporting date
02 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
13 Jun 2018
Reporting date
08 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

FORM 8-K

Filing date
03 May 2018
Reporting date
03 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

FORM 8-K

Filing date
08 Feb 2018
Reporting date
08 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
18 Jan 2018
Reporting date
15 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
08 Jan 2018
Reporting date
07 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
02 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

FORM 8-K

Filing date
08 Nov 2017
Reporting date
08 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-19034

8-K/A

Filing date
13 Sep 2017
Reporting date
13 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
14 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

FORM 8-K

Filing date
04 May 2017
Reporting date
04 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
09 Mar 2017
Reporting date
03 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

FORM 8-K

Filing date
09 Feb 2017
Reporting date
09 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
07 Feb 2017
Reporting date
02 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
31 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
09 Jan 2017
Reporting date
09 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
30 Dec 2016
Reporting date
30 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
21 Dec 2016
Reporting date
16 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
25 Nov 2016
Reporting date
18 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
18 Nov 2016
Reporting date
14 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .